首页 › 癌症（所有类型） › 得克萨斯州 › Dallas
Dallas TX 癌症（所有类型）临床试验
37项针对 癌症（所有类型）的研究正在 Dallas及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
招募中观察性研究
- UT Southwestern Medical Center, Dallas
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
招募中1 期
- GSK Investigational Site, Dallas
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
招募中2/3 期
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
- 以及另外 1 项
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
招募中1 期
- NEXT Oncology, Dallas
- SCRI at Mary Crowley, Dallas
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
招募中3 期
- Texas Oncology-Baylor Charles A Sammons Cancer Center, Dallas
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
招募中2/3 期
- Texas Oncology, Dallas
- Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
- UT Southwestern Medical Center, Dallas
Connect for Cancer Prevention Study (Connect)
招募中观察性研究欢迎健康志愿者
- Baylor Scott and White Health, Dallas
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
招募中2 期
- UT Southwestern Medical Center, Dallas
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
招募中1/2 期
- University of Texas - Southwestern Medical Center /ID# 271914, Dallas
Falcon Real World Evidence Registry
招募中观察性研究欢迎健康志愿者
- Baylor Scott & White Health, Dallas
A Phase 1/1b Study of IAM1363 in HER2 Cancers
招募中1 期
- Mary Crowley Cancer Research, Dallas
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
招募中3 期
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- Mary Crowley Cancer Research, Dallas
Perioperative FLOT(D) With Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Esophageal Cancer
招募中1 期
- University of Texas Southwestern Medical Center, Dallas
Project: Every Child for Younger Patients With Cancer
招募中观察性研究
- Medical City Dallas Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Abatacept in Immune Checkpoint Inhibitor Myocarditis
招募中3 期
- University of Texas Southwestern, Dallas
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
招募中2 期
- University of Texas Southwestern Medical Center at Dallas, Dallas
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- Parkland Memorial Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study of ASP1002 in Adults for Treatment of Solid Tumors
招募中1 期
- Mary Crowley Cancer Research Center, Dallas
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
招募中1/2 期
- University of Texas - Southwestern Medical Center /ID# 274360, Dallas
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
招募中1 期
- Texas Oncology - Dallas - Worth Street /ID# 280064, Dallas
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
招募中观察性研究
- Liver Center of Texas, Dallas
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
招募中2 期
- University of Texas Southwestern Medical Center, Dallas
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
招募中1/2 期
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- University of Texas Southwestern, Dallas
Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung
招募中早期 I 期
- University of Texas Southwestern Medical Center, Dallas
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
招募中1 期
- GSK Investigational Site, Dallas
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
招募中
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
招募中1 期
- University of Texas Southwestern Medical Center /ID# 251974, Dallas
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
招募中1/2 期
- UT Southwestern Medical Center, Dallas
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
招募中1 期
- GSK Investigational Site, Dallas
A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients
招募中2 期
- Texas Oncology, Dallas
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation
招募中观察性研究
- UT Southwestern Medical Centre, Dallas
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
招募中1 期
- NEXT Dallas, Dallas
The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.
招募中观察性研究
- Baylor University Medical Center - Dallas, Dallas
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
招募中1 期
- NEXT Dallas, Dallas
Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer
招募中2 期
- University of Texas Southwestern Medical Center, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Dallas
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
招募中观察性研究
- UT Southwestern, Dallas
其他城市的 癌症（所有类型）试验
- Houston, TX121 项研究
- New York City, NY109 项研究
- Boston, MA85 项研究
- Los Angeles, CA74 项研究
- Nashville, TN65 项研究
- Philadelphia, PA59 项研究
- Washington, DC58 项研究
- Durham, NC58 项研究
- Chicago, IL51 项研究
- Atlanta, GA49 项研究
- Seattle, WA49 项研究
- Arlington, VA48 项研究
Dallas的其他研究
- 乳腺癌55 项研究
- 非小细胞肺癌52 项研究
- 转移性癌症42 项研究
- 心力衰竭42 项研究
- 前列腺癌36 项研究
- 结直肠癌33 项研究
- 肥胖症30 项研究
- 卵巢癌28 项研究
- 肺癌27 项研究
- 膀胱癌27 项研究
- 子宫内膜癌24 项研究
- 肾癌（肾细胞癌）23 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。